You are invited to the upcoming Research Grand Rounds on "Bacteriophages as a Therapeutic Agent – From Dumps to Trumps?".
About the Event
There is an increasing interest in non-traditional antibacterial therapeutics and innovative approaches to effectively treat difficult-to-treat infections and eradicate biofilms.
Join our speakers Dr Andrea Kwa and Dr Wilfried Moreira, as they set out to discuss what is phage therapy.
About the Speakers
Dr Andrea Kwa is the Deputy Director (Research), Pharmacy, at Singapore General Hospital (SGH). She is also an Associate Professor, Emerging Infectious Diseases Programme, at Duke-NUS Medical School. Specializing in critical care medicine, infectious diseases and antimicrobial resistance research, Dr Kwa is a keen trainer both in the research and clinical arenas of critical care and infectious diseases. With more than 20 years of clinical expertise, her research focus is of translational nature with direct applicability to patients with difficult-to-treat infections in the near future. She is also part of the Health Manpower Development Plan (HMDP) team with Dr Jasmine Chung.
Dr Wilfried Moreira is a Principal Investigator and Senior Research Fellow at Singapore Centre for Environmental Life Sciences Engineering (SCELSE) – National University of Singapore (NUS). He is a Molecular Microbiologist by training with over 10 years of experience in antimicrobial resistance, and has developed a bacteriophage isolation and engineering platform. His research interests include the identification of novel and vulnerable resistance pathways in pathogenic bacteria, and the development of bacteriophage-derived technologies. He was previously a Director for Research of the Antimicrobial Resistance Program at the Singapore-MIT Alliance for Research and Technology (SMART) centre.
About the Facilitator
Dr Jasmine Chung is the Director, Antimicrobial Stewardship Unit and Senior Consultant, Department of Infectious Diseases at Singapore General Hospital (SGH). She is an infectious diseases physician with special interest in infections in the immunocompromised hosts, and transplant-related infections as well as management of refractory and resistant infections. More recently, she completed a Health Manpower Development Plan (HMDP) team fellowship and visited the Center for Innovative Phage Applications and Therapeutics (IPATH) at University California San Diego.
Registration Details
Sign up here now or scan the QR code in the poster below.
